Gender Parity in Authorship of Published Randomized Clinical Trials in Stroke Neurology From 2000 to 2021.

Authors

Noor F Shaik, Thomas Jefferson UniversityFollow
Ali A Saherwala, Thomas Jefferson University
Diana L Tzeng, Thomas Jefferson UniversityFollow

Document Type

Article

Publication Date

3-1-2022

Comments

This is the final published version of the article from Jama Network Open, 2022 Mar 1;5(3):e222423.

The article is also available on the journal's website: https://doi.org/10.1001/jamanetworkopen.2022.2423

Copyright. The Authors

Publication made possible in part by support from the Jefferson Open Access Fund

Abstract

Gender parity is a crucial goal in clinical medicine so that women have equal access and representation. Although approximately half (46%) of US neurology residents and fellows are female, proportions of female assistant, associate, and full professors are 49%, 41%, and 23%, respectively. This has far-reaching effects, from clinical publications to invited speakerships.Although a study noted increasing trends in female authorship in high-impact neurology journals the current literature lacks evidence on a more informative benchmark—first and last authorship in randomized clinical trials (RCTs), which is typically considered for career advancement. This study assessed annual proportions and trends of female first and last authorship in neurovascular (stroke) RCTs from 2000 to 2021.

Recommended Citation

Shaik, Noor F; Saherwala, Ali A; and Tzeng, Diana L, "Gender Parity in Authorship of Published Randomized Clinical Trials in Stroke Neurology From 2000 to 2021." (2022). Department of Neurology Faculty Papers. Paper 286.
https://jdc.jefferson.edu/neurologyfp/286

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 License.

PubMed ID

35289864

Language

English